Summary
94.13 -0.62(-0.65%)06/28/2024
ESAB (ESAB)
ESAB (ESAB)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -0.65 | 1.19 | -0.73 | 38.82 | 27.45 | 54.94 | 0.00 | 769.01 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 94.13 | |
| Open | 95.04 | |
| High | 97.86 | |
| Low | 93.85 | |
| Volume | 221,904 | |
| Change | -0.62 | |
| Change % | -0.65 | |
| Avg Volume (20 Days) | 160,292 | |
| Volume/Avg Volume (20 Days) Ratio | 1.38 | |
| 52 Week Range | 54.49 - 88.39 | |
| Price vs 52 Week High | 6.49% | |
| Price vs 52 Week Low | 72.75% | |
| Range | -1.05 | |
| Gap Up/Down | -0.76 | |
Fundamentals | ||
| Market Capitalization (Mln) | 5,706 | |
| EBIDTA | 0 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 0.00 | |
| Book Value | 0.0000 | |
| Earnings Per Share | 0.0000 | |
| EPS Estimate Current Quarter | 0.0000 | |
| EPS Estimate Next Quarter | 0.0000 | |
| EPS Estimate Current Year | 0.0000 | |
| EPS Estimate Next Year | 0.0000 | |
| Diluted EPS (TTM) | 0.0000 | |
| Revenues | ||
| Profit Marging | 0.0000 | |
| Operating Marging (TTM) | 0.0000 | |
| Return on asset (TTM) | 0.0000 | |
| Return on equity (TTM) | 0.0000 | |
| Revenue TTM | 0 | |
| Revenue per share TTM | 0.0000 | |
| Quarterly Revenue Growth (YOY) | 0.0000 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | 0 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 0.0000 | |
| Revenue Enterprise Value | 0.0000 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 0 | |
| Shares Float | 0 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 0.00 | |
| Institutions (%) | 0.00 | |
06/26 12:45 EST - zacks.com
SKFRY vs. ESAB: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Metal Products - Procurement and Fabrication sector have probably already heard of AB SKF (SKFRY) and Esab (ESAB). But which of these two stocks presents investors with the better value opportunity right now?
SKFRY vs. ESAB: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Metal Products - Procurement and Fabrication sector have probably already heard of AB SKF (SKFRY) and Esab (ESAB). But which of these two stocks presents investors with the better value opportunity right now?
06/10 05:51 EST - zacks.com
Zacks Industry Outlook AB SKF, The Timken, ESAB, Kaiser Aluminum and Northwest Pipe
AB SKF, The Timken, ESAB, Kaiser Aluminum and Northwest Pipe have been highlighted in this Industry Outlook article.
Zacks Industry Outlook AB SKF, The Timken, ESAB, Kaiser Aluminum and Northwest Pipe
AB SKF, The Timken, ESAB, Kaiser Aluminum and Northwest Pipe have been highlighted in this Industry Outlook article.
06/07 10:56 EST - zacks.com
5 Metal Fabrication Stocks to Watch Amid Improving Industry Trends
Easing supply-chain issues and solid end-market demand should aid the Metal Products - Procurement and Fabrication industry's growth. SKFRY, TKR, ESAB, KALU and NWPX are some stocks to watch, backed by their healthy growth prospects.
5 Metal Fabrication Stocks to Watch Amid Improving Industry Trends
Easing supply-chain issues and solid end-market demand should aid the Metal Products - Procurement and Fabrication industry's growth. SKFRY, TKR, ESAB, KALU and NWPX are some stocks to watch, backed by their healthy growth prospects.
06/04 06:30 EST - businesswire.com
ESAB Announces Distribution Agreement With INFRA Group
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESABCorporation--ESAB Corporation announces distribution agreement with INFRA Group to expand the availability of ESAB's fabrication portfolio to customers in Mexico.
ESAB Announces Distribution Agreement With INFRA Group
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESABCorporation--ESAB Corporation announces distribution agreement with INFRA Group to expand the availability of ESAB's fabrication portfolio to customers in Mexico.
05/31 10:41 EST - zacks.com
Is ESAB Corporation (ESAB) Stock Outpacing Its Industrial Products Peers This Year?
Here is how Esab (ESAB) and DNOW (DNOW) have performed compared to their sector so far this year.
Is ESAB Corporation (ESAB) Stock Outpacing Its Industrial Products Peers This Year?
Here is how Esab (ESAB) and DNOW (DNOW) have performed compared to their sector so far this year.
05/30 06:30 EST - businesswire.com
ESAB Corporation Enters into Agreement to Acquire the Welding Business of Linde Bangladesh
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESABCorporation--ESAB Corporation announces agreement to acquire Linde Industries Private Limited (LIPL) a market leader in welding consumables in Bangladesh.
ESAB Corporation Enters into Agreement to Acquire the Welding Business of Linde Bangladesh
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESABCorporation--ESAB Corporation announces agreement to acquire Linde Industries Private Limited (LIPL) a market leader in welding consumables in Bangladesh.
05/27 10:56 EST - zacks.com
Here's Why Esab (ESAB) Could be Great Choice for a Bottom Fisher
After losing some value lately, a hammer chart pattern has been formed for Esab (ESAB), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Here's Why Esab (ESAB) Could be Great Choice for a Bottom Fisher
After losing some value lately, a hammer chart pattern has been formed for Esab (ESAB), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
05/20 01:03 EST - https://www.defenseworld.net
Enovis (NYSE:ENOV) vs. Envoy Medical (NASDAQ:COCH) Financial Survey
Enovis (NYSE:ENOV – Get Free Report) and Envoy Medical (NASDAQ:COCH – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership. Analyst Recommendations This is a breakdown of current ratings and target prices for Enovis and Envoy Medical, as reported by MarketBeat.com. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enovis 0 0 8 0 3.00 Envoy Medical 0 0 2 0 3.00 Enovis presently has a consensus target price of $75.43, indicating a potential upside of 43.92%. Envoy Medical has a consensus target price of $6.00, indicating a potential upside of 92.93%. Given Envoy Medical’s higher possible upside, analysts clearly believe Envoy Medical is more favorable than Enovis. Institutional and Insider Ownership 98.5% of Enovis shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 2.4% of Enovis shares are owned by insiders. Comparatively, 0.7% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Volatility & Risk Enovis has a beta of 1.99, meaning that its share price is 99% more volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.59, meaning that its share price is 159% more volatile than the S&P 500. Profitability This table compares Enovis and Envoy Medical’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Enovis -4.51% 3.98% 2.88% Envoy Medical N/A N/A -112.11% Valuation and Earnings This table compares Enovis and Envoy Medical’s gross revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Enovis $1.71 billion 1.68 -$33.26 million ($1.50) -34.94 Envoy Medical $316,000.00 192.90 -$29.91 million N/A N/A Envoy Medical has lower revenue, but higher earnings than Enovis. Summary Enovis beats Envoy Medical on 6 of the 11 factors compared between the two stocks. About Enovis (Get Free Report) Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware. About Envoy Medical (Get Free Report) Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Enovis (NYSE:ENOV) vs. Envoy Medical (NASDAQ:COCH) Financial Survey
Enovis (NYSE:ENOV – Get Free Report) and Envoy Medical (NASDAQ:COCH – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership. Analyst Recommendations This is a breakdown of current ratings and target prices for Enovis and Envoy Medical, as reported by MarketBeat.com. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enovis 0 0 8 0 3.00 Envoy Medical 0 0 2 0 3.00 Enovis presently has a consensus target price of $75.43, indicating a potential upside of 43.92%. Envoy Medical has a consensus target price of $6.00, indicating a potential upside of 92.93%. Given Envoy Medical’s higher possible upside, analysts clearly believe Envoy Medical is more favorable than Enovis. Institutional and Insider Ownership 98.5% of Enovis shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 2.4% of Enovis shares are owned by insiders. Comparatively, 0.7% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Volatility & Risk Enovis has a beta of 1.99, meaning that its share price is 99% more volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.59, meaning that its share price is 159% more volatile than the S&P 500. Profitability This table compares Enovis and Envoy Medical’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Enovis -4.51% 3.98% 2.88% Envoy Medical N/A N/A -112.11% Valuation and Earnings This table compares Enovis and Envoy Medical’s gross revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Enovis $1.71 billion 1.68 -$33.26 million ($1.50) -34.94 Envoy Medical $316,000.00 192.90 -$29.91 million N/A N/A Envoy Medical has lower revenue, but higher earnings than Enovis. Summary Enovis beats Envoy Medical on 6 of the 11 factors compared between the two stocks. About Enovis (Get Free Report) Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware. About Envoy Medical (Get Free Report) Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
05/15 09:50 EST - zacks.com
4 Stocks to Watch That Recently Announced Dividend Hikes
Curtiss-Wright Corporation (CW), Murphy USA Inc. (MUSA), ESAB Corporation (ESAB) and Victory Capital Holdings, Inc. (VCTR) recently hiked dividends.
4 Stocks to Watch That Recently Announced Dividend Hikes
Curtiss-Wright Corporation (CW), Murphy USA Inc. (MUSA), ESAB Corporation (ESAB) and Victory Capital Holdings, Inc. (VCTR) recently hiked dividends.
05/13 13:01 EST - zacks.com
Are You Looking for a Top Momentum Pick? Why Esab (ESAB) is a Great Choice
Does Esab (ESAB) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are You Looking for a Top Momentum Pick? Why Esab (ESAB) is a Great Choice
Does Esab (ESAB) have what it takes to be a top stock pick for momentum investors? Let's find out.
05/09 16:30 EST - businesswire.com
ESAB Corporation Board Declares Increased Dividend
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESABCorporation--ESAB Corporation Board Declares Increased Dividend.
ESAB Corporation Board Declares Increased Dividend
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESABCorporation--ESAB Corporation Board Declares Increased Dividend.
05/01 06:30 EST - businesswire.com
ESAB Corporation Announces First Quarter 2024 Results
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESABCorporation--ESAB Corporation 1Q 2024 Earnings.
ESAB Corporation Announces First Quarter 2024 Results
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESABCorporation--ESAB Corporation 1Q 2024 Earnings.
04/25 10:46 EST - zacks.com
Is ESAB Corporation (ESAB) Outperforming Other Industrial Products Stocks This Year?
Here is how Esab (ESAB) and Eaton (ETN) have performed compared to their sector so far this year.
Is ESAB Corporation (ESAB) Outperforming Other Industrial Products Stocks This Year?
Here is how Esab (ESAB) and Eaton (ETN) have performed compared to their sector so far this year.
04/24 11:07 EST - zacks.com
Esab (ESAB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Esab (ESAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Esab (ESAB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Esab (ESAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
04/22 12:46 EST - zacks.com
TKR vs. ESAB: Which Stock Should Value Investors Buy Now?
Investors interested in Metal Products - Procurement and Fabrication stocks are likely familiar with Timken (TKR) and Esab (ESAB). But which of these two stocks presents investors with the better value opportunity right now?
TKR vs. ESAB: Which Stock Should Value Investors Buy Now?
Investors interested in Metal Products - Procurement and Fabrication stocks are likely familiar with Timken (TKR) and Esab (ESAB). But which of these two stocks presents investors with the better value opportunity right now?
04/08 06:30 EST - businesswire.com
ESAB Corporation Releases Second Annual Sustainability Report
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESABCorporation--ESAB Corporation releases second annual sustainability report and new commitment to 50% global electricity coming from renewable sources by 2030.
ESAB Corporation Releases Second Annual Sustainability Report
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESABCorporation--ESAB Corporation releases second annual sustainability report and new commitment to 50% global electricity coming from renewable sources by 2030.
04/04 07:00 EST - businesswire.com
ESAB Corporation Schedules First Quarter 2024 Earnings Release and Conference Call
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESAB1Q24Earnings--ESAB Corporation Schedules First Quarter 2024 Earnings Release and Conference Call.
ESAB Corporation Schedules First Quarter 2024 Earnings Release and Conference Call
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESAB1Q24Earnings--ESAB Corporation Schedules First Quarter 2024 Earnings Release and Conference Call.
04/01 12:46 EST - zacks.com
NHYDY or ESAB: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Metal Products - Procurement and Fabrication sector might want to consider either Norsk Hydro ASA (NHYDY) or Esab (ESAB). But which of these two stocks is more attractive to value investors?
NHYDY or ESAB: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Metal Products - Procurement and Fabrication sector might want to consider either Norsk Hydro ASA (NHYDY) or Esab (ESAB). But which of these two stocks is more attractive to value investors?
03/25 17:58 EST - businesswire.com
ESAB Corporation Announces Upsizing and Pricing of its 6.25% Senior Notes due 2029
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESAB--ESAB Corporation Announces Upsizing and Pricing of its 6.25% Senior Notes due 2029.
ESAB Corporation Announces Upsizing and Pricing of its 6.25% Senior Notes due 2029
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESAB--ESAB Corporation Announces Upsizing and Pricing of its 6.25% Senior Notes due 2029.
03/25 08:07 EST - businesswire.com
ESAB Corporation Announces Offering of Senior Notes
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESAB--ESAB announced today that it intends to offer senior notes.
ESAB Corporation Announces Offering of Senior Notes
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESAB--ESAB announced today that it intends to offer senior notes.